Suppr超能文献

老年人高血压——综述

Hypertension in elderly--an overview.

作者信息

Bhattacharyya A, Das P

出版信息

J Indian Med Assoc. 1999 Mar;97(3):96-101.

Abstract

Hypertension (HT) is a common disease in elderly. It has different pathophysiologic, clinical and therapeutic implications in this age group. Due to loss of arterial wall elasticity with age, major vessels including aorta become stiff and less distensible. As age advances, these stiff vessels also lose beta adrenergic responsiveness with unchanged alpha adrenergic responsiveness. These together raise peripheral vascular resistance and aortic impedance which needs a powerful systolic ejection of left ventricle to maintain cardiac output. Result is rise in systolic blood pressure (SBP) and increase in left ventricular (LV) mass with compromised cardiac output and renal blood flow. Participation of renin-angiotensin system and kidney in HT pathogenesis in elderly are minimum. Diagnosis of HT in elderly is made if SBP > 140 mm Hg and/or diastolic blood pressure (DBP) > 90 mm Hg or is taking antihypertensive medications. Isolated systolic hypertension (ISH) means SBP > 140 mm Hg with DBP < 90 mm Hg. Measurement of blood pressure (BP) is problematic, mainly due to pseudo HT, postural hypotension and white-coat HT. HT in absence of end organ changes suggest pseudo HT. Postural hypotension must be detected and treated. Systolodiastolic HT, carried over from middle age is the commonest type of HT in elderly. ISH is also common (10%). Atherosclerotic renovascular disease can cause secondary HT. Therapy is always needed in HT in elderly. Chance of coronary artery disease (CAD) and cerebrovascular accident (CVA) are quite high amongst elderly hypertensives. SBP is more dangerous than DBP. Benefits of therapy are more when compared to young. HT should be treated if SBP > 160 mm Hg and/or DBP > 90 mm Hg. ISH needs therapy if SBP > 160 mm Hg. The benefits of therapy becomes less after 80 years. Treatment goal should be to keep BP below 140/90 mm Hg. Therapy should be gradual and stepwise. Na-restriction should be modest. Diuretics (e.g., thiazide 25 mg/day) are the drug of choice unless contra-indicated. Beta blockers are inferior agents compared to diuretics unless angina or acute myocardial infarction (AMI) is present. Angiotensin converting enzyme (ACE) inhibitors are drug of choice only if congestive cardiac failure (CCF) and/or diabetes is present or other drugs are contra-indicated. Calcium entry blockers (CEB) are new but very good alternative to diuretics in elderly. Due to abnormal physiology, pharmacokinetics and drug interactions, side-effects are very common in elderly. They should be detected early and treated.

摘要

高血压(HT)是老年人的常见疾病。在这个年龄组中,它具有不同的病理生理、临床和治疗意义。由于动脉壁弹性随年龄增长而丧失,包括主动脉在内的主要血管变得僵硬且扩张性降低。随着年龄的增长,这些僵硬的血管β肾上腺素能反应性降低,而α肾上腺素能反应性不变。这些共同增加了外周血管阻力和主动脉阻抗,这需要左心室强有力的收缩射血来维持心输出量。结果是收缩压(SBP)升高,左心室(LV)质量增加,心输出量和肾血流量受损。肾素 - 血管紧张素系统和肾脏在老年人HT发病机制中的参与程度最低。如果收缩压>140 mmHg和/或舒张压(DBP)>90 mmHg或正在服用抗高血压药物,则可诊断为老年人高血压。单纯收缩期高血压(ISH)是指收缩压>140 mmHg且舒张压<90 mmHg。血压(BP)测量存在问题,主要是由于假性高血压、体位性低血压和白大衣高血压。无终末器官改变的高血压提示假性高血压。必须检测并治疗体位性低血压。从中年延续而来的收缩期舒张期高血压是老年人中最常见的高血压类型。ISH也很常见(10%)。动脉粥样硬化性肾血管疾病可导致继发性高血压。老年人高血压总是需要治疗。老年高血压患者患冠状动脉疾病(CAD)和脑血管意外(CVA)的几率相当高。收缩压比舒张压更危险。与年轻人相比,治疗的益处更大。如果收缩压>160 mmHg和/或舒张压>90 mmHg,则应治疗高血压。如果收缩压>160 mmHg,则ISH需要治疗。80岁以后治疗的益处会减少。治疗目标应是将血压保持在140/90 mmHg以下。治疗应循序渐进。钠限制应适度。利尿剂(如噻嗪类25毫克/天)是首选药物,除非有禁忌证。除非存在心绞痛或急性心肌梗死(AMI),否则β受体阻滞剂与利尿剂相比是较差的药物。仅当存在充血性心力衰竭(CCF)和/或糖尿病或其他药物有禁忌证时,血管紧张素转换酶(ACE)抑制剂才是首选药物。钙通道阻滞剂(CEB)是新药,但在老年人中是利尿剂的很好替代品。由于生理异常、药代动力学和药物相互作用,副作用在老年人中非常常见。应尽早发现并治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验